Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease

Cystatin C versus Creatinine in Determining Risk Based on Kidney Function

(2013) Michael G. Shlipak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

(2012) Benjamin F Voight et al.   LANCET

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

(2012) Lesley A. Inker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimated GFR Associates with Cardiovascular Risk Factors Independently of Measured GFR

(2011) U. D. Mathisen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

(2011) Georg B. Ehret et al.   NATURE

Improved estimation of glomerular filtration rate (GFR) by comparison of eGFRcystatin Cand eGFRcreatinine

(2011) Anders Grubb et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Cystatin C and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid Atherosclerosis

(2010) Matthias Hoke et al.   STROKE

Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome

(2009) Nevio Taglieri et al.   ATHEROSCLEROSIS

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Correlates and Heritability of Cystatin C (from the Framingham Offspring Study)

(2008) Nisha I. Parikh et al.   AMERICAN JOURNAL OF CARDIOLOGY